Supplemental Table 2 from Mitochondrial Uncoupling Induces Epigenome Remodeling and Promotes Differentiation in Neuroblastoma

Supplemental Table 2 from Mitochondrial Uncoupling Induces Epigenome Remodeling and Promotes Differentiation in Neuroblastoma

<p>Regional counting of differential methylated probes in SK-N-BE(2) cells treated with NEN for 24hrs under nomoxia. Go enrichment pathways of the differential methylated probes of the CpG Island in the promoter (B) (C) and gene body (D) (E)</p>

Zapisane w:

Opis bibliograficzny
1. autor:	Haowen Jiang (14963613) (author)
Kolejni autorzy:	Rachel L. Greathouse (14963616) (author), Sarah Jane Tiche (14963619) (author), Man Zhao (14963622) (author), Bo He (14963625) (author), Yang Li (14963628) (author), Albert M. Li (14963631) (author), Balint Forgo (14963634) (author), Michaela Yip (14963637) (author), Allison Li (14963640) (author), Moriah Shih (14963643) (author), Selene Banuelos (14963646) (author), Meng-Ning Zhou (14963649) (author), Joshua J. Gruber (14963652) (author), Erinn B. Rankin (14963655) (author), Zhen Hu (14963658) (author), Hiroyuki Shimada (14963661) (author), Bill Chiu (14963664) (author), Jiangbin Ye (14963667) (author)
Wydane:	2025
Hasła przedmiotowe:	Cancer Cancer Risk Factors Molecular and Cellular Biology Therapeutic Research and Development Epigenetics DNA methylation Gene Regulation Transcriptional control of cell differentiation Metabolism Warburg effect Pediatric Cancers Translational Research
Etykiety:	Dodaj etykietę Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy

Supplemental Table 1 from Mitochondrial Uncoupling Induces Epigenome Remodeling and Promotes Differentiation in Neuroblastoma
od: Haowen Jiang (14963613)
Wydane: (2025)

Supplemental Table 3 from Mitochondrial Uncoupling Induces Epigenome Remodeling and Promotes Differentiation in Neuroblastoma
od: Haowen Jiang (14963613)
Wydane: (2025)

Supplemental Table 4 from Mitochondrial Uncoupling Induces Epigenome Remodeling and Promotes Differentiation in Neuroblastoma
od: Haowen Jiang (14963613)
Wydane: (2025)

Supplementary Data 1. from The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer
od: Arian Lundberg (14960817)
Wydane: (2025)

Supplementary Data 2. from The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer
od: Arian Lundberg (14960817)
Wydane: (2025)

Supplementary Table 1. from The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer
od: Arian Lundberg (14960817)
Wydane: (2025)

Supplementary Table 2. from The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer
od: Arian Lundberg (14960817)
Wydane: (2025)

Supplementary Table 3. from The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer
od: Arian Lundberg (14960817)
Wydane: (2025)

Supplementary Data from β-Catenin–Driven Differentiation Is a Tissue-Specific Epigenetic Vulnerability in Adrenal Cancer
od: Dipika R. Mohan (15011204)
Wydane: (2025)

Supplementary Data 1 from KDM6A Loss Triggers an Epigenetic Switch That Disrupts Urothelial Differentiation and Drives Cell Proliferation in Bladder Cancer
od: Hong Qiu (14963144)
Wydane: (2025)

Supplementary Data 2 from KDM6A Loss Triggers an Epigenetic Switch That Disrupts Urothelial Differentiation and Drives Cell Proliferation in Bladder Cancer
od: Hong Qiu (14963144)
Wydane: (2025)

Table S1 from HTLV-1 bZIP Factor-Induced Reprogramming of Lactate Metabolism and Epigenetic Status Promote Leukemic Cell Expansion
od: Kosuke Toyoda (16698360)
Wydane: (2025)

Table S2 from HTLV-1 bZIP Factor-Induced Reprogramming of Lactate Metabolism and Epigenetic Status Promote Leukemic Cell Expansion
od: Kosuke Toyoda (16698360)
Wydane: (2025)

Table S3 from HTLV-1 bZIP Factor-Induced Reprogramming of Lactate Metabolism and Epigenetic Status Promote Leukemic Cell Expansion
od: Kosuke Toyoda (16698360)
Wydane: (2025)

Table S4 from HTLV-1 bZIP Factor-Induced Reprogramming of Lactate Metabolism and Epigenetic Status Promote Leukemic Cell Expansion
od: Kosuke Toyoda (16698360)
Wydane: (2025)

Supplementary Table S3 from Deficiency of the Polycomb Protein RYBP and TET Methylcytosine Oxidases Promotes Extensive CpG Island Hypermethylation and Malignant Transformation
od: Wei Cui (16721390)
Wydane: (2025)

Supplementary Table S4 from Deficiency of the Polycomb Protein RYBP and TET Methylcytosine Oxidases Promotes Extensive CpG Island Hypermethylation and Malignant Transformation
od: Wei Cui (16721390)
Wydane: (2025)

Supplementary Table S5 from Deficiency of the Polycomb Protein RYBP and TET Methylcytosine Oxidases Promotes Extensive CpG Island Hypermethylation and Malignant Transformation
od: Wei Cui (16721390)
Wydane: (2025)

Supplementary Table S6 from Deficiency of the Polycomb Protein RYBP and TET Methylcytosine Oxidases Promotes Extensive CpG Island Hypermethylation and Malignant Transformation
od: Wei Cui (16721390)
Wydane: (2025)

Supplementary Table S7 from Deficiency of the Polycomb Protein RYBP and TET Methylcytosine Oxidases Promotes Extensive CpG Island Hypermethylation and Malignant Transformation
od: Wei Cui (16721390)
Wydane: (2025)

Table S3 from Caffeine Supplementation and FOXM1 Inhibition Enhance the Antitumor Effect of Statins in Neuroblastoma
od: Gia-Buu Tran (16437051)
Wydane: (2025)

Table S4 from Caffeine Supplementation and FOXM1 Inhibition Enhance the Antitumor Effect of Statins in Neuroblastoma
od: Gia-Buu Tran (16437051)
Wydane: (2025)

Table S5 from Caffeine Supplementation and FOXM1 Inhibition Enhance the Antitumor Effect of Statins in Neuroblastoma
od: Gia-Buu Tran (16437051)
Wydane: (2025)

Supplementary Table S1 from Caffeine Supplementation and FOXM1 Inhibition Enhance the Antitumor Effect of Statins in Neuroblastoma
od: Gia-Buu Tran (16437051)
Wydane: (2025)

Supplementary Table S2 from Caffeine Supplementation and FOXM1 Inhibition Enhance the Antitumor Effect of Statins in Neuroblastoma
od: Gia-Buu Tran (16437051)
Wydane: (2025)

Supplementary Data from HAND2 Assists MYCN Enhancer Invasion to Regulate a Noradrenergic Neuroblastoma Phenotype
od: Man Xu (14963249)
Wydane: (2025)

Supplementary Data from HAND2 Assists MYCN Enhancer Invasion to Regulate a Noradrenergic Neuroblastoma Phenotype
od: Man Xu (14963249)
Wydane: (2025)

Supplementary Data from HAND2 Assists MYCN Enhancer Invasion to Regulate a Noradrenergic Neuroblastoma Phenotype
od: Man Xu (14963249)
Wydane: (2025)

Supplementary Data from HAND2 Assists MYCN Enhancer Invasion to Regulate a Noradrenergic Neuroblastoma Phenotype
od: Man Xu (14963249)
Wydane: (2025)

Supplementary Data from HAND2 Assists MYCN Enhancer Invasion to Regulate a Noradrenergic Neuroblastoma Phenotype
od: Man Xu (14963249)
Wydane: (2025)

Supplementary Data from HAND2 Assists MYCN Enhancer Invasion to Regulate a Noradrenergic Neuroblastoma Phenotype
od: Man Xu (14963249)
Wydane: (2025)

Supplementary Data from HAND2 Assists MYCN Enhancer Invasion to Regulate a Noradrenergic Neuroblastoma Phenotype
od: Man Xu (14963249)
Wydane: (2025)

Supplementary Data from HAND2 Assists MYCN Enhancer Invasion to Regulate a Noradrenergic Neuroblastoma Phenotype
od: Man Xu (14963249)
Wydane: (2025)

Supplementary Tables TS1-23 from An Enhancer Demethylator Phenotype Converged to Immune Dysfunction and Resistance to Immune Checkpoint Inhibitors in Clear-Cell Renal Cell Carcinomas
od: Xiaofan Lu (15049989)
Wydane: (2025)

Table S1 from Dysregulation of Mitochondrial Translation Caused by <i>CBFB</i> Deficiency Cooperates with Mutant PIK3CA and Is a Vulnerability in Breast Cancer
od: Navdeep Malik (15293148)
Wydane: (2025)

Table S2 from Dysregulation of Mitochondrial Translation Caused by <i>CBFB</i> Deficiency Cooperates with Mutant PIK3CA and Is a Vulnerability in Breast Cancer
od: Navdeep Malik (15293148)
Wydane: (2025)

Table S3 from Dysregulation of Mitochondrial Translation Caused by <i>CBFB</i> Deficiency Cooperates with Mutant PIK3CA and Is a Vulnerability in Breast Cancer
od: Navdeep Malik (15293148)
Wydane: (2025)

Table S4. from Dysregulation of Mitochondrial Translation Caused by <i>CBFB</i> Deficiency Cooperates with Mutant PIK3CA and Is a Vulnerability in Breast Cancer
od: Navdeep Malik (15293148)
Wydane: (2025)

Supplementary Figure S7 from <i>NPY</i> Methylated ctDNA is a Promising Biomarker for Treatment Response Monitoring in Metastatic Colorectal Cancer
od: Katleen Janssens (15053356)
Wydane: (2025)

Data file S1 from Targeting STAT5 Signaling Overcomes Resistance to IDH Inhibitors in Acute Myeloid Leukemia through Suppression of Stemness
od: Alex C.H. Liu (14961921)
Wydane: (2025)

Cannot write session to /tmp/vufind_sessions/sess_8kfb2u0up9fclussmoq6maib32